Skip to main content

Peer Review reports

From: Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System

Original Submission
7 Oct 2022 Submitted Original manuscript
27 Feb 2023 Reviewed Reviewer Report
19 Mar 2023 Reviewed Reviewer Report
22 Apr 2023 Author responded Author comments - U-Syn Ha
Resubmission - Version 2
22 Apr 2023 Submitted Manuscript version 2
8 May 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
22 May 2023 Editorially accepted
30 May 2023 Article published 10.1186/s12885-023-10991-3

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us